Synthesis, X-ray characterization and evaluation of potent anti-angiogenic activity of a novel copper(II)-imidazole-bipyridyl complex

In this study, 1-(4-(trifluoromethyl)benzyl)-1H-imidazole, (ImCF 3 ) and 2,2′-bipyridyl, (bipy) ligands coordinating copper(II) complex have been synthesized and successfully characterized by single crystal X-ray diffraction, FT-IR and UV-vis and elemental analysis techniques. The agreement between...

Full description

Saved in:
Bibliographic Details
Published in:Inorganic and nano-metal chemistry 2022-08, Vol.52 (8), p.1153-1160
Main Authors: Ünver, Hakan, Dıkmen, Gökhan, Kiyan, Hülya Tuba
Format: Article
Language:English
Subjects:
anti-angiogenic
Copper
imidazole
in vivo CAM assay
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this study, 1-(4-(trifluoromethyl)benzyl)-1H-imidazole, (ImCF 3 ) and 2,2′-bipyridyl, (bipy) ligands coordinating copper(II) complex have been synthesized and successfully characterized by single crystal X-ray diffraction, FT-IR and UV-vis and elemental analysis techniques. The agreement between experimental and theoretical results have been observed. Information about local and global chemical activity, electrophilic and nucleophilic nature of copper(II) complex have been theoretically obtained. The anti-angiogenic activity results indicated that copper(II) complex showed significantly very strong anti-angiogenic potential with higher anti-angiogenic score (average score = 1.06 ± 0.01) than the standard anti-angiogenic (±)-Thalidomide (average score = 0.8 ± 0.2) with no irritation and embryotoxicity whereas both ligands of the complex showed weak anti-angiogenic effects and one of the ligands ImCF 3 showed significant and higher irritation potential (86 ± 20%) when compared with the standard irritant agent SDS (84 ± 10%) on the CAM at 50 µg/pellet.
ISSN:2470-1556
2470-1564
DOI:10.1080/24701556.2021.1963279